Wordt geladen...
Adjuvant and Neoadjuvant Systemic Therapy for Pancreas Adenocarcinoma
The last two decades of research in the adjuvant setting of pancreas adenocarcinoma have established the value of adjuvant systemic therapy as being able to delay recurrence and increase overall survival. International standards of care in the adjuvant setting include either 6 months of gemcitabine...
Bewaard in:
| Gepubliceerd in: | Semin Oncol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4991774/ https://ncbi.nlm.nih.gov/pubmed/25726058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2014.12.012 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|